How liver cancer develops

Liver cancer usually starts when cells in the liver begin to grow abnormally and multiply without control. Most liver cancers are hepatocellular carcinoma (HCC), which arises from the main type of liver cell called a hepatocyte. The cancer typically develops over years as the liver sustains repeated injury from one or more causes — the damage triggers inflammation, which leads to scarring (cirrhosis), and cirrhotic tissue is where cancer cells most often take hold.

The process is not inevitable. Many people with liver damage never develop cancer. But the longer the injury continues, the higher the risk becomes. Understanding what causes that initial damage is the key to understanding why some people develop liver cancer and others do not.

Key Takeaways

  • Chronic hepatitis B and hepatitis C infections are the leading causes of liver cancer worldwide, accounting for the majority of cases.
  • Cirrhosis — permanent scarring from any cause — is present in about 80 to 90 percent of liver cancer cases, though cirrhosis itself does not always lead to cancer.
  • Alcohol-related liver disease and non-alcoholic fatty liver disease (NAFLD) are rising causes of liver cancer in developed countries.
  • Inherited conditions like hemochromatosis and alpha-1 antitrypsin deficiency increase liver cancer risk by causing iron or protein buildup in liver tissue.
  • Some people develop liver cancer without cirrhosis, particularly those with chronic hepatitis B, so the presence of cirrhosis is not required for cancer to form.

Hepatitis B and C infections

Chronic hepatitis B is the single largest cause of liver cancer globally. The virus infects liver cells and triggers ongoing inflammation. Over decades, this inflammation damages the liver tissue, leading to cirrhosis. People infected with hepatitis B have a 15 to 40 percent lifetime risk of developing liver cancer, even if they develop cirrhosis.

Chronic hepatitis C works similarly but typically takes longer — usually 20 to 30 years of infection before cirrhosis develops. Once cirrhosis is present, the annual risk of liver cancer is roughly 1 to 5 percent per year. Unlike hepatitis B, hepatitis C rarely causes cancer without first causing cirrhosis.

Both viruses can be transmitted through blood contact (sharing needles, transfusions before screening was routine) or, in the case of hepatitis B, through sexual contact or from mother to child at birth. Modern screening has made transfusion-related transmission rare in developed countries, but many people infected decades ago remain unaware of their status.

Alcohol-related liver disease

Heavy, prolonged alcohol use damages liver cells directly and triggers inflammation and scarring. Alcohol-related liver disease progresses through stages: fatty liver (reversible), alcoholic hepatitis (inflammation), and cirrhosis (permanent scarring). Liver cancer typically emerges only after cirrhosis has developed.

The amount and duration of drinking that leads to cirrhosis varies between individuals — genetics, sex, body weight, and overall nutrition all play a role. There is no safe threshold below which alcohol causes no risk, but the risk rises sharply with daily consumption above certain levels. Once cirrhosis is present, the annual risk of liver cancer is 1 to 3 percent per year.

Alcohol-related liver cancer is increasing in developed countries, particularly in North America and Europe, where it now rivals hepatitis C as a cause.

Non-alcoholic fatty liver disease (NAFLD)

Non-alcoholic fatty liver disease (NAFLD) occurs when fat accumulates in liver cells without significant alcohol use. It is closely linked to obesity, type 2 diabetes, and metabolic syndrome. NAFLD affects roughly 25 to 30 percent of adults in developed countries, making it the most common liver condition overall.

Most people with NAFLD have simple fatty liver and never develop advanced disease. However, in some people the condition progresses to non-alcoholic steatohepatitis (NASH) — a more aggressive form with inflammation and cell death. NASH can lead to cirrhosis, and cirrhotic NASH carries a 1 to 3 percent annual risk of liver cancer.

Importantly, liver cancer from NAFLD is rising as obesity rates climb. Unlike hepatitis C, NAFLD-related cancer can sometimes develop without cirrhosis, though this is less common. The exact mechanisms that allow some NAFLD patients to progress to cancer while others do not remain incompletely understood.

Cirrhosis from other causes

Any condition that causes chronic liver damage can lead to cirrhosis and increase cancer risk. Autoimmune hepatitis occurs when the immune system attacks liver cells; primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) damage the bile ducts; and hemochromatosis causes iron to accumulate in the liver, triggering oxidative damage.

Alpha-1 antitrypsin deficiency is an inherited condition where the liver cannot properly clear a protein, leading to buildup and damage. People with this deficiency have a substantially elevated lifetime risk of liver cancer even without cirrhosis.

These conditions account for a smaller percentage of liver cancer cases than hepatitis or alcohol-related disease, but they are important to identify because some (like hemochromatosis and alpha-1 deficiency) can be managed to slow or prevent progression if caught early.

Cirrhosis and cancer risk

Cirrhosis is present in 80 to 90 percent of liver cancer cases, but the relationship is not one-to-one. Cirrhosis itself does not cause cancer — rather, the scarring and inflammation that define cirrhosis create an environment where cancer cells are more likely to arise. The annual risk of developing liver cancer in a person with cirrhosis ranges from 1 to 5 percent depending on the underlying cause and other factors.

Importantly, not everyone with cirrhosis develops cancer. Some people live for many years with stable cirrhosis and never develop malignancy. Conversely, some people develop liver cancer without ever developing cirrhosis — this is more common in chronic hepatitis B and in advanced NAFLD, where the cancer can arise from inflamed but not yet scarred tissue.

Age, sex, and genetic factors

Liver cancer is more common in men than women, a difference that partly reflects higher rates of hepatitis B and C infection in men historically, as well as higher alcohol consumption in many populations. Age also matters: liver cancer risk rises with age, typically appearing after age 50, though it can occur earlier in people with long-standing cirrhosis.

Genetic factors influence both susceptibility to liver disease and progression to cancer. People with certain genetic variants may be more likely to develop cirrhosis from hepatitis C or to progress more rapidly from NAFLD to NASH. Family history of liver cancer is a risk factor, though it often reflects shared exposure to hepatitis or shared metabolic traits rather than inherited cancer predisposition.

Frequently Asked Questions

Can you get liver cancer without cirrhosis?

Yes, though it is less common. Chronic hepatitis B can cause liver cancer even in people without cirrhosis, as can advanced NAFLD. However, the majority of liver cancer cases do occur in people with cirrhosis. The presence or absence of cirrhosis does not determine whether cancer will develop.

If I have hepatitis B or C, will I definitely get liver cancer?

No. Many people with chronic hepatitis B or C never develop cancer, even after decades of infection. Risk depends on the viral load, how long you have been infected, your age, your sex, and whether cirrhosis has developed. Regular monitoring can detect cancer early if it does arise.

Does fatty liver always turn into cancer?

No. Most people with simple fatty liver never develop advanced disease or cancer. Only a subset progress to NASH and then cirrhosis. Risk is higher in people with obesity, diabetes, or metabolic syndrome, but progression is not inevitable.

How long does it usually take for liver damage to become cancer?

It varies widely. Hepatitis C typically takes 20 to 30 years to progress to cirrhosis, and then several more years before cancer appears. Alcohol-related cirrhosis can develop faster — sometimes in 5 to 10 years of heavy drinking. NAFLD progression is slower and more variable. Some people never progress despite decades of liver disease.

Can liver cancer develop if I stop drinking or treat my hepatitis?

If cirrhosis has already developed, the risk of liver cancer remains elevated even after you stop drinking or clear a hepatitis infection. However, stopping further damage can slow or halt progression. People with treated hepatitis C and stable cirrhosis still require monitoring for cancer, as do people who have stopped drinking but retain cirrhotic tissue.